Skip to main content
Clinical Trials/NCT01556620
NCT01556620CompletedNot Applicable

The New 4 Wavelengths EQUANOX NIRS Sensor: Correlation and Detection of Ischemic Episodes. An Observational Comparative Study Versus PtiO2

Direction Centrale du Service de Santé des Armées1 site in 1 country8 target enrollmentStarted: November 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
8
Locations
1

Study Overview

Brief Summary

We hypothesize that newly developped NIRS sensor (EQUANOX Advance™, 8004CA, NONIN Medical, USA)is able to detect ischemic events recorded by brain tissue oxygen probe (Licox, Integra Neurosciences, USA) and that values are correlated.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Necessity of monitoring by PtiO2 and ICP

Exclusion Criteria

  • Inability to apply NIRS sensor

Investigators

Sponsor
Direction Centrale du Service de Santé des Armées
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

BORET Henry

Médecin en Chef

Direction Centrale du Service de Santé des Armées

Study Sites (1)

Loading locations...

Similar Trials